- Home
- RNAZ vs DUKRW Comparison
RNAZ vs DUKRW Comparison
Compare RNAZ & DUKRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.90
N/A
Current Price
$1.22
Company Overview
Basic Information| Metric | RNAZ | DUKRW |
|---|---|---|
| Founded | 2016 | N/A |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Aerospace |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6M | 4.3M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | RNAZ | DUKRW |
|---|---|---|
| Price | $2.90 | $1.22 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 24.0K | 2.6K |
| Earning Date | 04-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $377,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 249.07 |
| 52 Week Low | $2.87 | $0.10 |
| 52 Week High | $20.99 | $1.78 |
Technical Indicators
Market Signals| Indicator | RNAZ | DUKRW |
|---|---|---|
| Relative Strength Index (RSI) | 28.76 | 51.68 |
| Support Level | N/A | $0.82 |
| Resistance Level | $6.15 | $1.29 |
| Average True Range (ATR) | 0.36 | 0.23 |
| MACD | -0.02 | 0.06 |
| Stochastic Oscillator | 8.33 | 66.67 |
Price Performance
Historical Comparison RNAZ
DUKRW
About RNAZ TransCode Therapeutics Inc.
TransCode Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of RNA-based therapeutics and immuno-oncology treatments for cancer. The company's lead candidate, TTX-MC138, targets microRNA-10b and has completed a Phase 1a clinical trial, while it is also advancing additional product candidates, including a cancer vaccine and an oncolytic immunotherapy platform.